Cargando…

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life

Hepatitis C virus (HCV) response to direct-acting antivirals (DAAs) may be influenced by the presence of resistance-associated substitutions (RASs). This study aimed to assess if NS5A baseline RAS-guided treatment enhances the rate of sustained viral response (SVR) in naïve HCV-infected patients in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Real, Luis M., Macías, Juan, Pérez, Ana B., Merino, Dolores, Granados, Rafael, Morano, Luis, Delgado, Marcial, Ríos, María J., Galera, Carlos, Deltoro, Miguel G., Merchante, Nicolás, García, Federico, Pineda, Juan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175866/ https://www.ncbi.nlm.nih.gov/pubmed/30297726 http://dx.doi.org/10.1038/s41598-018-33367-1

Ejemplares similares

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection
por: Real, Luis Miguel, et al.
Publicado: (2019)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
por: Merchante, Nicolás, et al.
Publicado: (2015)

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
por: Núñez-Torres, Rocío, et al.
Publicado: (2016)

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014
por: Neukam, Karin, et al.
Publicado: (2016)

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV
por: Rivero-Juárez, Antonio, et al.
Publicado: (2013)

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure
por: Corma-Gómez, Anaïs, et al.
Publicado: (2021)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2014)

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
por: Brochado-Kith, Óscar, et al.
Publicado: (2019)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals
por: Rivero-Juárez, Antonio, et al.
Publicado: (2020)

Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection
por: Merchante, Nicolás, et al.
Publicado: (2021)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
por: Pérez, Ana Belén, et al.
Publicado: (2019)

Recent advances in the anti-HCV mechanisms of interferon
por: Huang, Menghao, et al.
Publicado: (2014)

Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians
por: Real, Luis M., et al.
Publicado: (2014)

Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs
por: Paolucci, Stefania, et al.
Publicado: (2017)

Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
por: Kleefeld, Felix, et al.
Publicado: (2017)

Regulation of the Interferon Response by lncRNAs in HCV Infection
por: Valadkhan, Saba, et al.
Publicado: (2018)

Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
por: Moghe, Akshata, et al.
Publicado: (2017)

Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients
por: Tripathi, Gaurav, et al.
Publicado: (2022)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
por: Brochado, Óscar, et al.
Publicado: (2021)

Enhanced anti-HCV activity of interferon alpha 17 subtype
por: Dubois, Aurelie, et al.
Publicado: (2009)

Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCV
por: Laidlaw, Stephen M., et al.
Publicado: (2014)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

Regulation of interferon signaling and HCV-RNA replication by extracellular matrix
por: Kuwashiro, Takuya, et al.
Publicado: (2018)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

Complicaciones arteriales trombóticas en pacientes hospitalizados con COVID-19
por: Rey, Juan R., et al.
Publicado: (2020)

Arterial thrombotic complications in hospitalized patients with COVID-19
por: Rey, Juan R., et al.
Publicado: (2020)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2gk2oo88qiugm8l80ae58pvgp0